Older Americans screened for cancer despite limited benefits
the ONA take:
According to a new report in The Journal of the American Medical Association Internal Medicine, up to 50% of older people in the United States received cancer screening despite a high probability that they would die without cancer within the next 9 years. Trevor Royce, MD, MS, of the University of North Carolina at Chapel Hill and his colleagues agree that routine cancer screenings has minimal benefits for patients with a limited life expectancy.
In the study, the researchers assessed responses from 27,404 people at least 65 years old. Based on their responses, the researchers estimated their probability of death within the next 9 years and then identified which of those had recently been screened for breast, cervical, colon, and prostate cancers.
They found that 55% of men who had a 75% risk of death had received a prostate specific antigen (PSA) screening. Approximately 33% of women with a 75% risk of death received breast and cervical cancer screenings. In addition, 41% of people who were not likely to live another 10 years received colon cancer screenings.
The American Cancer Society and other professional societies recommend stopping PSA screening in men who are not expected to live another 10 years.
Despite potential risks, many are still screened for cancers toward the end of their lives.
Up to half of older people in the U.S. received cancer screenings even though there was a high likelihood that they would die within nine years without cancer, researchers report in JAMA Internal Medicine.
“There is general agreement that routine cancer screening has little likelihood to result in a net benefit for individuals with limited life expectancy,” write Dr. Trevor Royce and his fellow researchers from the University of North Carolina, Chapel Hill. Several professional societies have updated their cancer screening guidelines to suggest that people who aren't expected to live another 10 years should not be screened for certain cancers.
- Response to Anemia Treatment Differs in Lymphoma, Multiple Myeloma
- Fertility Preservation in Male Adolescents and Young Adults With Cancer
- Impact of Prostate Cancer Diagnosis, Treatment Choice on Quality of Life
- Social, Psychiatric Variables Reduce Cognitive Functioning, QoL in HNC
- Duloxetine May Improve AI-Associated Joint Pain in Early Stage Breast Cancer
- HPV and Cancer (Fact Sheet)
- Pain Control More Easily Achieved With Nurse-Led Education in Bone Metastases
- Acupuncture an Effective Alternative Treatment for Cancer-Related Fatigue
- Using Nutrition-Based Strategies to Manage Adverse Effects of Cancer
- Palliative Care Associated With Decreased Costs For Patients With Advanced Cancer
- Exercise May Mitigate Doxorubicin-related Cardiotoxicity
- Reduced Delayed Intensification Impacts Risk of Pediatric ALL Relapse
- Exercise May Mitigate Cardiotoxicity Associated With Doxorubicin Treatment
- Mobile Health Apps Becoming More Popular Among Patients and Clinicians
- Online Learning Modules Improve Exercise Counseling, But Not Participation
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|